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Introduction
Fetal dysrhythmias are reported in approximately 1–2% 
of all pregnancies and are a relatively common reason for 
referral to fetal medicine centers1-3. Fetal tachycardia is a 
serious condition in which the fetus is at risk of congestive 
heart failure and the subsequent development of hydrops1-4. 
This situation is associated with significant morbidity and 
mortality1-4. In general, the diagnosis and assessment of these 
dysrhythmias can be accurately made using high-resolution 
2-D ultrasound using M mode and Doppler assessment of the 
relationship between the atrial and ventricular contractions5. 
Junctional ectopic tachycardia (JET) is a rare form of fetal 
tachyarrhythmia, which usually occurs in the setting of 
surgery for congenital heart disease6. In addition, a congenital 
variety of JET not related to surgery has also been described. 
While post-surgical JET has a mortality up to 14%, congenital 
JET has a mortality up to 34%6. The congenital form of JET 
has rarely been reported during the prenatal period7,8. We 
describe a case in which the diagnosis was suspected in 
utero in a patient referred to our Department because of 
the presence of important fetal ascitis. The diagnosis was 
based on the evidence of moderate tachyarrhythmia episodes 
without 1:1 AV relationship and intermittent absence of 
atrial contraction wave consistent with atrioventricular (AV) 
dissociation, together with ductus venosus reverse diastolic 
wave indicating mild cardiac failure. JET diagnosis was 
confirmed after birth.
Case Report
A 32-year-old woman, gravid 1, was referred to our 
Department at 23 weeks’ gestational age because of 
the presence of important fetal ascitis. On ultrasound 
examination (Voluson e8, GE), no heart or other structural 
anomalies were noted, fetal growth was adequate for 
gestational age, and polyhydramnios as well as ascitis were 
observed, indicating fetal hydrops. Ventricular tachycardia 
episodes without 1:1 AV relationship and atrioventricular 
(AV) dissociation were observed (figure 1). In addition, 
a ductus venosus reverse diastolic wave was also noted. 
Fetal diagnosis was AV dissociation with either JET or 
ventricular tachycardia. Fetal JET was suspected on the 
basis of ventricular tachycardia episodes rarely exceeding 
190 bpm without 1:1 AV relationship and atrioventricular 
(AV) dissociation, together with ductus venosus reverse 
diastolic wave and hydrops indicating cardiac failure. 
Thus, the fetus was diagnosed as having tachyarrhythmia, 
consistent with JET, and hydrops.  The pregnant woman 
was admitted for an attempt of cardioversion with digoxin. 
After normal maternal ECG and electrolytes, treatment was 
started with oral digoxin 0.25 mg at 6 hourly intervals for a 
total of 2 mg, followed by a daily dose 0.25 mg at 8 hourly 
intervals. Once digoxin was within the therapeutic range 
(0.8-2 ng/ml), the patient was discharged and fetomaternal 
therapy monitoring was performed in an outpatient basis. 
Treatment control was based in maternal digoxinemia and 
ECG, as well as fetal ultrasonography twice a week. Blood 
digoxin level kept at therapeutic range during treatment, 
amniotic fluid volume returned to normal range, and fetal 
ascitis get reduced and remained stable, despite ductus 
venosus reverse diastolic wave indicating mild cardiac failure. 
Despite that response, at 28 weeks gestation we decided to 
give betametasone injections to promote lung maturation as 
prolongation of pregnancy was not guaranteed due to the 
general unfavorable prognosis and difficult management of 
JET or VT. At 34 weeks’gestational age, a cesarean section was 
performed due to the appearance of sudden and permanent 
fetal tachycardia despite digoxin therapy. A male weighing 
2500 g with Apgar score 10/10/10 was born and the newborn 
was admitted for study at the Neonatology Department. At 
admission, neonatal ECG showed a regular narrow QRS 
tachycardia with AV dissociation, and the diagnose of JET was 
established (Figure 2). Treatment with adenosine was started 
to completely rule out an atrial flutter. As far as JET diagnosis 
was confirmed, we used propranolol only, and amiodarone 
associated to propranolol as well, but with poor outcome. 
Currently, the newborn is 9 month of age, presents a similar 
characteristic EKG and he is being treated with propranolol 
and flecainide. He shows a very good ventricular function 
(EF 72%) by echocardiography and an EKG holter recording 
with an average frequency 138 bpm.
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Discussion 
Cardiac arrhythmias are detected in approximately 1% 
of all fetuses1,2 . Most of these rhythm disturbances are the 
result of extrasystoles and are of little clinical significance1,2. 
The incidence of fetal tachycardia is 1:10,000 to 1:25,000. 
Fetal tachyarrhythmias can result in the development of 
congestive heart failure and therefore prenatal intervention 
may be necessary1,2.  Junctional ectopic tachycardia is usually 
seen in children during the immediate postoperative period of 
congenital heart surgery. The congenital form is less frequent 
and has rarely been reported prenatally7,8. Congenital JET is 
believed to be caused by an automatic ectopic focus in the AV 
junction3. In general, prenatal differential diagnosis between 
JET and VT on fetal echocardiogram is a challenge. In our case, 
the diagnosis of JET in utero was suspected on the basis of 
ventricular tachycardia episodes rarely exceeding 190 beats/
min without 1:1 AV relationship and atrioventricular (AV) 
dissociation, together with ductus venosus reverse diastolic 
wave and ascitis indicating cardiac failure. 
The optimal treatment of fetal tachyarrhythmias remains 
undetermined. The safety of the mother is of great concern 
when managing fetal tachycardia, as administration of 
antiarrhythmic drugs for intrauterine treatment may cause 
pro-arrhythmia and threaten the mother. Digoxin has been 
widely accepted as the mainstay of therapy because of its 
safety and convenient administration1,2,5. Flecainide, sotalol 
and amiodarone has also been used in the treatment of fetal 
tachyarrhythmias5,9,10. However, more serious side effects on 
both mother and fetus have been a concern5. 
The outcome in congenital JET shows that is a malignant 
tachyarrhythmia causing tachycardia-induced cardiomyopathy 
and sudden death6. Because of the limited efficiency of 
most antiarrhythmic medications in JET, the intrauterine 
management of such cases is difficult and should aim at 
maintaining adequate cardiac output to allow prolongation 
of the pregnancy until lung maturation is achieved7,8. In 
addition, the presence of hydrops in our case suggested an 
unfavorable prognosis, despite the fact that, before digoxin 
therapy, tachyarrhythmia was episodic and ventricular rate 
rarely exceeded 190 beats/min.
In the case reported here, digoxin therapy was enough to 
control fetal heart rate, reduce fetal ascitis and keep amniotic 
fluid within the normal range, despite ductus venosus reverse 
diastolic wave indicating mild cardiac failure. Finally, at 34 
weeks’ gestation the fetus became non-responder to digoxin 
therapy and we decided to terminate pregnancy to avoid 
further fetal cardiac deterioration.
In conclusion, we report a case of complicated fetal JET that 
underwent transplacental fetal therapy with digoxin. Prenatal 
management of fetal arrhythmia is important to improve 
Figure 1 - A & B:  AV dissociation with moderate ventricular tachycardia in M mode. C:  intermittent absence of atrial contraction wave. D: ventricular tachycardia at 188 
b/min in M mode. 
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the outcome of affected fetus. Accurate prenatal diagnosis 
is crucial to the selection of the appropriate prenatal and 
postnatal treatments. Fetal JET is a rare condition and prenatal 
diagnosis remains a challenge, however differential diagnosis 
of fetal tachyarrhythmia should include this disorder.
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Figure 2 - Neonatal ECG showing a regular narrow QRS tachycardia with AV dissociation.
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